Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ginsberg

Showing results (81-90 of 369) with videos related to

Pageof 37
Sort By:
Journal of Lipid Research|April 1, 1990
Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB productionY Arad, R Ramakrishnan, H N Ginsberg
The Journal of Biological Chemistry|October 4, 1996
Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cellsM Zhou, X Wu, H N Ginsberg
Current Opinion in Lipidology|April 22, 2021
Nonalcohol fatty liver disease: balancing supply and utilization of triglyceridesLeinys S Santos-Baez, Henry N Ginsberg
Metabolism: Clinical and Experimental|May 1, 1992
Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteinsY Arad, R Ramakrishnan, H N Ginsberg
The Journal of Biological Chemistry|September 12, 1998
Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory proteinM Zhou, E A Fisher, H N Ginsberg
The American Journal of Cardiology|March 25, 2008
Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart diseaseMichael Miller, Henry N Ginsberg, Ernst J Schaefer
Metabolism: Clinical and Experimental|October 24, 2007
Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistanceShinichiro Saito, Antonio Hernandez-Ono, Henry N Ginsberg
Current Opinion in Lipidology|March 11, 2024
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolismJing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Arteriosclerosis (Dallas, Tex.)|March 1, 1990
Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patientsH N Ginsberg, S J Goldsmith, S Vallabhajosula
Pharmacology & Therapeutics|February 13, 2025
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?Alberto Corsini, Henry N Ginsberg, M John Chapman
Pageof 37

Showing results (81-90 of 369) with videos related to

Sort By:
Pageof 37
Journal of Lipid Research|April 1, 1990
Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB productionY Arad, R Ramakrishnan, H N Ginsberg
The Journal of Biological Chemistry|October 4, 1996
Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cellsM Zhou, X Wu, H N Ginsberg
Current Opinion in Lipidology|April 22, 2021
Nonalcohol fatty liver disease: balancing supply and utilization of triglyceridesLeinys S Santos-Baez, Henry N Ginsberg
Metabolism: Clinical and Experimental|May 1, 1992
Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteinsY Arad, R Ramakrishnan, H N Ginsberg
The Journal of Biological Chemistry|September 12, 1998
Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory proteinM Zhou, E A Fisher, H N Ginsberg
The American Journal of Cardiology|March 25, 2008
Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart diseaseMichael Miller, Henry N Ginsberg, Ernst J Schaefer
Metabolism: Clinical and Experimental|October 24, 2007
Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistanceShinichiro Saito, Antonio Hernandez-Ono, Henry N Ginsberg
Current Opinion in Lipidology|March 11, 2024
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolismJing Liu, Henry N Ginsberg, Gissette Reyes-Soffer
Arteriosclerosis (Dallas, Tex.)|March 1, 1990
Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patientsH N Ginsberg, S J Goldsmith, S Vallabhajosula
Pharmacology & Therapeutics|February 13, 2025
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?Alberto Corsini, Henry N Ginsberg, M John Chapman
Pageof 37